Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pomeroy

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Molecular Cancer Therapeutics|October 1, 2020
Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic OsteosarcomaBranden A Smeester, Garrett M Draper, Nicholas J Slipek, et al.
Bioorganic & Medicinal Chemistry|January 14, 2025
Modeling, synthesis and cell-based evaluation of pyridine-substituted analogs of CD3254 and fluorinated analogs of CBt-PMN as novel therapeuticsPeter W Jurutka, Zainab Khan, Ichiro Kaneko, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2024
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapiesJoseph G Skeate, Emily J Pomeroy, Nicholas J Slipek, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Molecular Cancer Therapeutics|October 1, 2020
Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic OsteosarcomaBranden A Smeester, Garrett M Draper, Nicholas J Slipek, et al.
Bioorganic & Medicinal Chemistry|January 14, 2025
Modeling, synthesis and cell-based evaluation of pyridine-substituted analogs of CD3254 and fluorinated analogs of CBt-PMN as novel therapeuticsPeter W Jurutka, Zainab Khan, Ichiro Kaneko, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2024
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapiesJoseph G Skeate, Emily J Pomeroy, Nicholas J Slipek, et al.
Pageof 8